Is the Donor Part of the Product? A Systematic Review of Patient Factors Affecting Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate Composition and Clinical Response

Background: Platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) vary in composition and are associated with heterogeneous clinical outcomes. We examined donor, procedural, and disease-related factors associated with product composition and clinical prognosis. Methods: Six databases and registers were searched. Eighteen human studies were included. Two independent reviewers assessed risk of bias using Quality in Prognosis Studies (QUIPS), and certainty was rated using a Grading of Recommendations Assessment, Development and Evaluation (GRADE)-informed approach. Because of heterogeneity, findings were synthesized narratively. Results: Thirteen studies concerned PRP (seven composition, six clinical) and five concerned BMAC (three composition, two clinical). Baseline whole-blood platelet count was positively associated with final PRP platelet concentration in two studies (low-certainty evidence), without establishing greater administered platelet dose or clinical benefit. BMAC cellular yield varied with harvesting conditions and cellular assay definitions; demographic associations were inconsistent. Associations between radiographic osteoarthritis severity and outcomes after PRP were heterogeneous and of very-low certainty. Conclusions: Donor biology and processing characteristics are associated with selected orthobiologic product measures, but corresponding clinical implications remain uncertain. Single-arm prognostic studies cannot establish treatment-effect modification or composition-mediated benefit. Registration: PROSPERO CRD420261483107. Level of Evidence: Level III; systematic review of predominantly observational and prognostic-factor studies.

Authors

Institutions

Publication Details

Journal
Bioengineering
Published
2026-11-16
DOI
https://doi.org/10.3390/bioengineering13111364
Primary Topic
Periodontal Regeneration and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Is the Donor Part of the Product? A Systematic Review of Patient Factors Affecting Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate Composition and Clinical Response

Mattia Alessio-Mazzola, Giacomo Placella, Vincenzo Salini, Francesco PEZONE et al.
1 links
Bioengineering
Periodontal Regeneration and Treatments
article

Is the Donor Part of the Product? A Systematic Review of Patient Factors Affecting Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate Composition and Clinical Response

Mattia Alessio-Mazzola, Giacomo Placella, Vincenzo Salini, Francesco PEZONE, Giulia D’Andrea, Carolina Dembowski
article en

Abstract

Background: Platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) vary in composition and are associated with heterogeneous clinical outcomes. We examined donor, procedural, and disease-related factors associated with product composition and clinical prognosis. Methods: Six databases and registers were searched. Eighteen human studies were included. Two independent reviewers assessed risk of bias using Quality in Prognosis Studies (QUIPS), and certainty was rated using a Grading of Recommendations Assessment, Development and Evaluation (GRADE)-informed approach. Because of heterogeneity, findings were synthesized narratively. Results: Thirteen studies concerned PRP (seven composition, six clinical) and five concerned BMAC (three composition, two clinical). Baseline whole-blood platelet count was positively associated with final PRP platelet concentration in two studies (low-certainty evidence), without establishing greater administered platelet dose or clinical benefit. BMAC cellular yield varied with harvesting conditions and cellular assay definitions; demographic associations were inconsistent. Associations between radiographic osteoarthritis severity and outcomes after PRP were heterogeneous and of very-low certainty. Conclusions: Donor biology and processing characteristics are associated with selected orthobiologic product measures, but corresponding clinical implications remain uncertain. Single-arm prognostic studies cannot establish treatment-effect modification or composition-mediated benefit. Registration: PROSPERO CRD420261483107. Level of Evidence: Level III; systematic review of predominantly observational and prognostic-factor studies.

BioengineeringVol. 13(11)
Vita-Salute San Raffaele University (IT), IRCCS Ospedale San Raffaele (IT)
Good health and well-being
Periodontal Regeneration and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon